Loading...
Plandaí Biotechnology, Inc.
PLPL•PNK
Financial Services
Shell Companies
$0.00
$0.00(0.00%)

Over the last four quarters, Plandaí Biotechnology, Inc. achieved steady financial progress, growing revenue from $0.00 in Q1 2023 to $0.00 in Q4 2023. Gross profit stayed firm with margins at N/A in Q4 2023 versus N/A in Q1 2023. Operating income totaled -$3.81M in Q4 2023, maintaining a N/A margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$3.60M. Net income dropped to -$3.60M, with EPS at -$0.00. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan